BETHLEHEM, Pa., Nov. 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of
care diagnostic tests and specimen collection devices, today announced the appointment of Stephen S. Tang, Ph.D., as Chairman of
the Company’s Board of Directors (the “Board”), effective November 14, 2016. Dr. Tang has been a Board member since April 2011, has
served as Chairman of the Compensation Committee since May 2014 and is also a member of the Nominating and Corporate Governance
Committee.
“We are pleased to announce Steve’s appointment as our new Chairman of the Board,” said Douglas A. Michels,
President and CEO of OraSure Technologies. “Steve has been a Director for over five years and has been a strong contributor
to our Board, including most recently as Chairman of the Compensation Committee. He currently serves as President and CEO of
The University City Science Center, an innovation and entrepreneurship hub for the Greater Philadelphia region. Steve has a broad
range of executive leadership experience from the life sciences industry along with an extensive background in business and
technology development matters. Steve’s demonstrated leadership and strong business skills will be invaluable in his new role
as Chairman of the Board.”
The Company also announced today the retirement of Douglas G. Watson as a Director and Chairman of Board,
effective November 13, 2016. Mr. Watson has been a Director since May 2002 and has served as Chairman of the Board since
March 2003. He has also served on the Audit and Compensation Committees.
“On behalf of the Company and the other Directors, I would like to express my deepest appreciation to Doug for
his service to the Company and the Board of Directors,” said Mr. Michels. “During Doug’s tenure as Chairman, the Company
experienced significant growth and accomplished many noteworthy strategic objectives. Doug’s strong leadership, wise counsel
and commitment to the Company have contributed to this success and he will be greatly missed. We wish him and his family
nothing but good health and success for the future.”
With Dr. Tang’s appointment and Mr. Watson’s retirement, the Board made the following additional Board
assignment changes involving existing Directors:
- Dr. Tang has relinquished his position as Chairman of the Compensation Committee, but will continue to serve as a member of
that Committee as well as the Nominating and Corporate Governance Committee.
- Ronny Lancaster has been appointed to replace Dr. Tang as Chairman of the Compensation Committee. Mr. Lancaster has
been a Director since May 2003, has served as Chairman of the Nominating and Corporate Governance Committee since May 2005 and
has served as a member of the Compensation Committee. He also previously served on the Audit Committee. Mr. Lancaster
has relinquished his position as Chairman of the Nominating and Corporate Governance Committee, but will continue to serve as a
member of that Committee.
- Charles W. Patrick has been appointed to replace Mr. Lancaster as the Chairman of the Nominating and Corporate Governance
Committee. Mr. Patrick has been a Director since January 2006 and has served on the Audit Committee and the Nominating and
Corporate Governance Committee.
About OraSure Technologies
OraSure Technologies is a leader in the development, manufacture and distribution of point of care diagnostic
and collection devices and other technologies designed to detect or diagnose critical medical conditions. Its first-to-market,
innovative products include rapid tests for the detection of antibodies to HIV and HCV on the OraQuick® platform, oral
fluid sample collection, stabilization and preparation products for molecular diagnostic applications, and oral fluid laboratory
tests for detecting various drugs of abuse. OraSure's portfolio of products is sold globally to various clinical laboratories,
hospitals, clinics, community-based organizations and other public health organizations, research and academic institutions,
distributors, government agencies, physicians' offices, commercial and industrial entities and consumers. The Company's products
enable healthcare providers to deliver critical information to patients, empowering them to make decisions to improve and protect
their health.
For more information on OraSure Technologies, please visit www.orasure.com.
Company Contact: Ronald H. Spair Chief Financial Officer 610-882-1820 Investorinfo@orasure.com www.orasure.com
